Aethlon Medical Inc (AEMD)
NASDAQ:AEMD
Holding AEMD?
Track your performance easily

Aethlon Medical (AEMD) Income Statement

509 Followers

Aethlon Medical Income Statement

Last quarter (Q1 2025), Aethlon Medical's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, Aethlon Medical's net income was $-2.57M. See Aethlon Medical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
--$ 574.25K$ 294.17K$ 659.10K$ 650.19K
Cost of Revenue
------
Gross Profit
--$ 574.25K$ 294.17K$ 659.10K$ 650.19K
Operating Expense
$ 11.85M$ 12.64M$ 12.47M$ 10.72M$ 8.55M$ 6.58M
Operating Income
$ -11.85M$ -12.64M$ -11.90M$ -10.42M$ -7.89M$ -5.93M
Net Non Operating Interest Income Expense
$ 351.83K$ 428.39K$ 10.97K-$ -1.58K$ -54.23K
Other Income Expense
--$ 142.12K--$ 395.82K
Pretax Income
$ -11.50M$ -12.21M$ -12.03M$ -10.42M$ -7.89M$ -6.38M
Tax Provision
----$ -551.00K$ -446.00K
Earnings From Equity Interest Net Of Tax
--$ -142.12K---
Net Income Common Stockholders
$ -11.50M$ -12.21M$ -12.03M$ -10.42M$ -7.89M$ -6.37M
Basic EPS
$ -3.85$ -4.86$ -5.90$ -0.71$ -0.65$ -1.87
Diluted EPS
$ -3.85$ -4.86$ -5.90$ -0.71$ -0.65$ -1.87
Basic Average Shares
$ 15.08M$ 2.51M$ 2.05M$ 14.76M$ 12.09M$ 3.41M
Diluted Average Shares
$ 15.08M$ 2.51M$ 2.05M$ 14.76M$ 12.09M$ 3.41M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 11.85M$ 12.64M$ 12.47M$ 10.72M$ 8.55M$ 6.58M
Net Income From Continuing And Discontinued Operation
$ -11.50M$ -12.21M$ -12.03M$ -10.42M$ -7.89M$ -6.37M
Normalized Income
$ -8.98M-----
Interest Expense
------
EBIT
$ -11.74M$ -12.21M$ -12.03M$ -10.42M$ -7.89M$ -6.33M
EBITDA
$ -11.38M$ -11.85M$ -11.79M$ -10.30M$ -7.85M$ -6.27M
Currency in USD

Aethlon Medical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis